Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naïve in Penta-Relapsed Refractory Multiple Myeloma (RRMM)

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.4277-4278
Main Authors: Mammadzadeh, Aytaj, Peng, Fulei, Atrash, Shebli, Hashmi, Hamza, Mohan, Meera, Alkharabsheh, Omar, Afrough, Aimaz, Cui, Wei, Mahmoudjafari, Zahra, Abdallah, Al-Ola
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1852-f77e53d5002330cc527511a96ab38b8b3627f226551b9dbb2b5f415e5d0905963
cites
container_end_page 4278
container_issue Supplement 1
container_start_page 4277
container_title Blood
container_volume 140
creator Mammadzadeh, Aytaj
Peng, Fulei
Atrash, Shebli
Hashmi, Hamza
Mohan, Meera
Alkharabsheh, Omar
Afrough, Aimaz
Cui, Wei
Mahmoudjafari, Zahra
Abdallah, Al-Ola
description
doi_str_mv 10.1182/blood-2022-165762
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_165762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122034127</els_id><sourcerecordid>S0006497122034127</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1852-f77e53d5002330cc527511a96ab38b8b3627f226551b9dbb2b5f415e5d0905963</originalsourceid><addsrcrecordid>eNp9kEtOwzAQhi0EEqVwAHZetguD7dR5iFX64CE1tKoKLCPHmdCgJI7stCK34QYcgouRtqxZjTT6v18zH0LXjN4w5vPbpNA6JZxyTpgrPJefoB4T3CeUcnqKepRSl4wCj52jC2s_KGUjh4se-lpsG6VLsFhneCmbHKrG4reNxqEBPJ5EIR6MiYKiwKVstqZL6AqHVZO_QzXE09yAaiDF6w0YWbddeLoe4tlnrW23fbXHimf5870DnFd42fVLsoJC1vvACjIjVaNNi6Nt0eR1AThqodClxIPVKoqGl-gsk4WFq7_ZRy_3s_XkkcwXD0-TcE4U8wUnmeeBcFLRves4VCnBPcGYDFyZOH7iJ47LvYxzVwiWBGmS8ERkIyZApDSgInCdPmLHXmW0tQayuDZ5KU0bMxrvFccHxfFecXxU3DF3Rwa6w3Y5mNiqTqCC9KAlTnX-D_0LLdiC9Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naïve in Penta-Relapsed Refractory Multiple Myeloma (RRMM)</title><source>ScienceDirect (Online service)</source><creator>Mammadzadeh, Aytaj ; Peng, Fulei ; Atrash, Shebli ; Hashmi, Hamza ; Mohan, Meera ; Alkharabsheh, Omar ; Afrough, Aimaz ; Cui, Wei ; Mahmoudjafari, Zahra ; Abdallah, Al-Ola</creator><creatorcontrib>Mammadzadeh, Aytaj ; Peng, Fulei ; Atrash, Shebli ; Hashmi, Hamza ; Mohan, Meera ; Alkharabsheh, Omar ; Afrough, Aimaz ; Cui, Wei ; Mahmoudjafari, Zahra ; Abdallah, Al-Ola</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-165762</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.4277-4278</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1852-f77e53d5002330cc527511a96ab38b8b3627f226551b9dbb2b5f415e5d0905963</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497122034127$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids></links><search><creatorcontrib>Mammadzadeh, Aytaj</creatorcontrib><creatorcontrib>Peng, Fulei</creatorcontrib><creatorcontrib>Atrash, Shebli</creatorcontrib><creatorcontrib>Hashmi, Hamza</creatorcontrib><creatorcontrib>Mohan, Meera</creatorcontrib><creatorcontrib>Alkharabsheh, Omar</creatorcontrib><creatorcontrib>Afrough, Aimaz</creatorcontrib><creatorcontrib>Cui, Wei</creatorcontrib><creatorcontrib>Mahmoudjafari, Zahra</creatorcontrib><creatorcontrib>Abdallah, Al-Ola</creatorcontrib><title>Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naïve in Penta-Relapsed Refractory Multiple Myeloma (RRMM)</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kEtOwzAQhi0EEqVwAHZetguD7dR5iFX64CE1tKoKLCPHmdCgJI7stCK34QYcgouRtqxZjTT6v18zH0LXjN4w5vPbpNA6JZxyTpgrPJefoB4T3CeUcnqKepRSl4wCj52jC2s_KGUjh4se-lpsG6VLsFhneCmbHKrG4reNxqEBPJ5EIR6MiYKiwKVstqZL6AqHVZO_QzXE09yAaiDF6w0YWbddeLoe4tlnrW23fbXHimf5870DnFd42fVLsoJC1vvACjIjVaNNi6Nt0eR1AThqodClxIPVKoqGl-gsk4WFq7_ZRy_3s_XkkcwXD0-TcE4U8wUnmeeBcFLRves4VCnBPcGYDFyZOH7iJ47LvYxzVwiWBGmS8ERkIyZApDSgInCdPmLHXmW0tQayuDZ5KU0bMxrvFccHxfFecXxU3DF3Rwa6w3Y5mNiqTqCC9KAlTnX-D_0LLdiC9Q</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Mammadzadeh, Aytaj</creator><creator>Peng, Fulei</creator><creator>Atrash, Shebli</creator><creator>Hashmi, Hamza</creator><creator>Mohan, Meera</creator><creator>Alkharabsheh, Omar</creator><creator>Afrough, Aimaz</creator><creator>Cui, Wei</creator><creator>Mahmoudjafari, Zahra</creator><creator>Abdallah, Al-Ola</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naïve in Penta-Relapsed Refractory Multiple Myeloma (RRMM)</title><author>Mammadzadeh, Aytaj ; Peng, Fulei ; Atrash, Shebli ; Hashmi, Hamza ; Mohan, Meera ; Alkharabsheh, Omar ; Afrough, Aimaz ; Cui, Wei ; Mahmoudjafari, Zahra ; Abdallah, Al-Ola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1852-f77e53d5002330cc527511a96ab38b8b3627f226551b9dbb2b5f415e5d0905963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mammadzadeh, Aytaj</creatorcontrib><creatorcontrib>Peng, Fulei</creatorcontrib><creatorcontrib>Atrash, Shebli</creatorcontrib><creatorcontrib>Hashmi, Hamza</creatorcontrib><creatorcontrib>Mohan, Meera</creatorcontrib><creatorcontrib>Alkharabsheh, Omar</creatorcontrib><creatorcontrib>Afrough, Aimaz</creatorcontrib><creatorcontrib>Cui, Wei</creatorcontrib><creatorcontrib>Mahmoudjafari, Zahra</creatorcontrib><creatorcontrib>Abdallah, Al-Ola</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mammadzadeh, Aytaj</au><au>Peng, Fulei</au><au>Atrash, Shebli</au><au>Hashmi, Hamza</au><au>Mohan, Meera</au><au>Alkharabsheh, Omar</au><au>Afrough, Aimaz</au><au>Cui, Wei</au><au>Mahmoudjafari, Zahra</au><au>Abdallah, Al-Ola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naïve in Penta-Relapsed Refractory Multiple Myeloma (RRMM)</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>4277</spage><epage>4278</epage><pages>4277-4278</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-165762</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.4277-4278
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_165762
source ScienceDirect (Online service)
title Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naïve in Penta-Relapsed Refractory Multiple Myeloma (RRMM)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A17%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20Patients%20Who%20Are%20BCMA%20(B-cell%20maturation%20Antigen)%20Directed%20Therapy%20(BDT)%20Exposed%20Vs%20BCMA%20Na%C3%AFve%20in%20Penta-Relapsed%20Refractory%20Multiple%20Myeloma%20(RRMM)&rft.jtitle=Blood&rft.au=Mammadzadeh,%20Aytaj&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=4277&rft.epage=4278&rft.pages=4277-4278&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-165762&rft_dat=%3Celsevier_cross%3ES0006497122034127%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1852-f77e53d5002330cc527511a96ab38b8b3627f226551b9dbb2b5f415e5d0905963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true